Pancreatic Cancer Research

ResearcherUniversity of ToyamaActive in the last 2 years

Kohei Nagata

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1487-4676; OpenAlex author ID A5065749372. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2026: 4 papers

Papers 4

  1. Third-Line Treatment Timing After Second-Line Discontinuation in Advanced Pancreatic Cancer: A 30-Day Landmark Analysis. Co-author DOI 10.1007/s12029-026-01565-0↗
  2. Clinical trajectories from first-line chemotherapy to best supportive care in unresectable pancreatic cancer: a 10-year real-world retrospective study. Co-author DOI 10.1016/j.ctarc.2026.101409↗
  3. Chemotherapy for Unresectable Pancreatic Cancer Complicated by Disseminated Intravascular Coagulation: A Retrospective Cohort Study. Co-author DOI 10.1097/mpa.0000000000002707↗
  4. Longitudinal Changes in Inflammatory and Nutritional Status Are Associated With Survival in Advanced Pancreatic Cancer. Co-author DOI 10.1177/10966218261500247↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nobuhiko Hayashi · 4 shared papers, 2026 · strength 1.07
  2. Banri Ogino · 4 shared papers, 2026 · strength 1.07
  3. Ichiro Yasuda · 4 shared papers, 2026 · strength 1.07
  4. Shinya Kajiura · 4 shared papers, 2026 · strength 1.07
  5. Kazuto Tajiri · 3 shared papers, 2026 · strength 0.81

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.